Abstract:Objective: Previous study showed that there was a close relationship between urinary levels of miR-196 a,miR-30a-5p, miR-490 and focal segmental glomerulosclerosis( FSGS). This study aimed to investigate the relationship between urinary miRNAs levels in patients with FSGS and the steroid therapy of FSGS. Methodology: A retrospective cohort analyzed primary FSGS patients treated with steroids. Meanwhile,a prospective cohort analyzed the priamry FSGS patients who were not treated before diagnosis,and then treated with steroids for eight weeks in the study.The urinary levels of miRNAs and proteinuria before treatment,after treatment,and in the middle of the treatment were tested,and the relationship between the levels of miRNAs and proteinuria was investigated. Results: In retrospective cohort,they were 139 patients,68 patients achieved CR( CR),while 71 of them did not( non-CR). Before treatment,the two groups had no significant difference in gender,age,proteinuria,serum creatinine level and cholesterol level. But the urinary level of miR-30a-5p in the group of non-CR was significantly lower than that in the group of CR( P = 0. 03).Urinary miR-30a-5p could marginally predict the response to steroid treatment in FSGS patients( AUC 0. 63,P = 0. 03).In prospective cohort,they were 55 patients,33 patients achieved CR( CR) after treatment,while 22 of them did not( non-CR). The urinary miR-30a-5p level declined as the remission in proteinuria( P < 0. 001),but in group of non-CR,it did not decrease after steroid therapy. The urinary levels of miRNAs before treatment at fourth and eighth weeks of the treatment were further examined in another 22 patients( 11 CR vs 11 non-CR). The urinary levels of miR-30a-5p decreased during the course of treatment in CR group( P < 0. 001). Differences in urinary miR-30a-5p levels between patients with and without CR were observed at the 4th week of therapy( P = 0. 003),prior to changes in proteinuria( P = 0. 29).Conclusion: The urinary level of miR-30a-5p directly related to the effect of the steroid therapy in patients with FSGS,and could predict the treatment response,and its change was prior to changes in proteinuria. Urinary miR-30a-5p could be used as a new predictive biomarker for prognosis and the treatment response of FSGS.

Urinary microRNAs are the biomarker for the disease activity of petients with focal segmental glomerulosclerosis

Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.

Circulating microRNAs and the disease activity of patients with focal segmental glomerulosclerosis

Plasma Microrna-186 and Proteinuria in Focal Segmental Glomerulosclerosis.

Urinary Mir-196A Predicts Disease Progression in Patients with Chronic Kidney Disease.

The serum levels of miRNAs in children with focal segmental glomerulosclerosis and children with minimal change disease

Differential Expression Of Urinary Exosomal Small Rnas In Idiopathic Membranous Nephropathy

Urinary miR-30a-5p predict treatment response of corticosteroid in patients with focal segmental glomerulosclerosis

Clinical Significance of Urinary Biomarkers in Patients with Primary Focal Segmental Glomerulosclerosis.

Serum Micrornas Levels in Primary Focal Segmental Glomerulosclerosis.

Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome

Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA network analysis

Urinary Mirna-29A-3p Levels Are Associated with Metabolic Parameters Via Regulation of IGF1 in Patients with Metabolic Syndrome.

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Comparison Of Glomerular Transcriptome Profiles Of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis And Minimal Change Disease

MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy

Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease

Urinary MicroRNA-10a and MicroRNA-30d Serve As Novel, Sensitive and Specific Biomarkers for Kidney Injury